Effect of Metabolic Syndrome Score, Metabolic Syndrome, and Its Individual Components on the Prevalence and Severity of Angiographic Coronary Artery Disease

被引:0
作者
Ming-Hui Gui
Yan Ling
Lin Liu
Jing-Jing Jiang
Xiao-Ying Li
Xin Gao
机构
[1] Department of Endocrinology and Metabolism, Shanghai Zhongshan Hospital, Fudan University
[2] Fudan Institute for Metabolic Diseases
关键词
Coronary Angiography; Coronary Artery Disease; Metabolic Syndrome; Metabolic Syndrome Score;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)]; R589 [代谢病];
学科分类号
1002 ; 100201 ;
摘要
Background: The clinical significance of metabolic syndrome(MS) score, MS, and its individual components with respect to risk prediction of coronary artery disease(CAD) remains unclear. The objective of this study was to investigate whether and to what extent MS score, MS, and its individual components were related to the risk of CAD.Methods: Among 1191 participants who underwent coronary angiography for the confirmation of suspected myocardial ischemia, 858 were included in this study according to the inclusion criteria from September 2010 to June 2013. MS was diagnosed with the 2005 National Cholesterol Education Program Adult Treatment Panel III criteria. The severity of coronary atherosclerosis was assessed by Gensini score.Results: The results showed that the age-and sex-adjusted odds ratios(ORs) for CAD were as follows: MS score, 1.327; MS, 2.013; elevated waist circumference, 1.447; reduced high-density lipoprotein cholesterol, 1.654; and elevated fasting glucose, 1.782; all P < 0.05; whereas for elevated triglycerides, 1.324, and elevated blood pressure, 1.342, both P > 0.05. After multivariate adjustment, results showed that only MS and elevated fasting glucose were significantly associated with CAD(OR, 1.628, 95% confidence interval [CI ], 1.151–2.305, P = 0.006 for elevated fasting glucose, and OR, 1.631, 95% CI, 1.208–2.203, P = 0.001 for MS). The study showed that only MS score and elevated fasting glucose were significantly associated with Gensini score(standardized coefficient, 0.101, P = 0.031 for elevated fasting glucose and standardized coefficient, 0.103, P = 0.009 for MS score).Conclusions: The present study demonstrated that MS score, MS, and its individual components might have different contributions to CAD prevalence and severity. MS and elevated fasting glucose were independent risk factors for the prevalence of angiographic CAD whereas MS score and elevated fasting glucose were significantly associated with the severity of CAD.
引用
收藏
页码:669 / 677
页数:9
相关论文
共 30 条
  • [21] Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population
    He, Y
    Jiang, B
    Wang, J
    Feng, K
    Chang, Q
    Fan, L
    Li, XY
    Hu, FB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) : 1588 - 1594
  • [22] Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
    Grundy, SM
    Cleeman, JI
    Daniels, SR
    Donato, KA
    Eckel, RH
    Franklin, BA
    Gordon, DJ
    Krauss, RM
    Savage, PJ
    Smith, SC
    Spertus, JA
    Costa, F
    [J]. CIRCULATION, 2005, 112 (17) : 2735 - 2752
  • [23] Metabolic syndrome and 10-year cardiovascular disease risk in the hoorn study
    Dekker, JM
    Girman, C
    Rhodes, T
    Nijpels, G
    Stehouwer, CDA
    Bouter, LM
    Heine, RJ
    [J]. CIRCULATION, 2005, 112 (05) : 666 - 673
  • [24] The obesity epidemic, metabolic syndrome and future prevention strategies
    James, PT
    Rigby, N
    Leach, R
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2004, 11 (01): : 3 - 8
  • [25] Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity
    Solymoss, BC
    Bourassa, MG
    Campeau, L
    Sniderman, A
    Marcil, M
    Lespérance, J
    Lévesque, S
    Varga, S
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (02) : 159 - 164
  • [26] Definition, diagnosis and classification of diabetes mellitus and its complications part 1: Diagnosis and classification of diabetes mellitus - Provisional report of a WHO consultation
    Alberti, KGMM
    Zimmet, PZ
    [J]. DIABETIC MEDICINE, 1998, 15 (07) : 539 - 553
  • [27] RELATION OF ARTERIOGRAPHICALLY DEFINED CORONARY-ARTERY DISEASE TO SERUM-LIPOPROTEIN PARTICLES MAPPED WITH MONOCLONAL-ANTIBODIES
    FIEVET, C
    NUTTENS, MC
    DUCIMETIERE, P
    FRUCHART, JC
    BERTRAND, M
    SALOMEZ, JL
    [J]. CIRCULATION, 1991, 84 (01) : 153 - 159
  • [28] Banting lecture 1988. Role of insulin resistance in human disease..[J].Reaven G M.Diabetes.1988, 12
  • [30] ESTIMATION OF CONCENTRATION OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN PLASMA, WITHOUT USE OF PREPARATIVE ULTRACENTRIFUGE
    FRIEDEWALD, WT
    FREDRICKSON, DS
    LEVY, RI
    [J]. CLINICAL CHEMISTRY, 1972, 18 (06) : 499 - +